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Summary 
The aim of this project was to explore drug deposition mechanisms on the aluminium canisters employed with 
Pressurised Metered Dose Inhalers (pMDIs). The investigation explored the influence of various surface treatments, 
applied to the canisters, to drug deposition phenomena. Physicochemical characterisation of the canisters was 
performed after the application of different surface treatments to explore potential links between: surface 
topography, surface chemical composition, total surface energy, and drug caking appearing on the canister walls. 
The coating treatments which were tested were; Fluorinated Ethylene Propylene (FEP) lacquer, vapour deposited 
Parylene and a 3M-proprietary, fluid-applied fluorosilane.  Anodisation was also explored both with and without 
additional fluorosilane treatment. A number of surface physicochemical characterisation techniques were employed, 
namely; Scanning Electron Microscopy (SEM), X-Ray Photoelectron Spectroscopy (XPS) and Contact Angle (CA) 
analysis. The data from these analyses were correlated with those from a Drug Deposition test employing drug 
quantification by UV spectrophotometry. The results obtained indicated a direct correlation of drug deposition on 
canister walls to the total surface free energy. The lowest total surface free energy values and lowest deposition 
values were seen when the 3M-proprietary fluorosilane coating was applied as the final treatment. In this case a 
surface free energy value of 15.73 mN/m and a percentage drug deposition of 7% compared to the calibration can, 
were achieved. 
Introduction 
Aerosol Inhalation therapy is the most widely used treatment for the common diseases of the lungs namely: Chronic 
Obstructive Pulmonary Disease (COPD), and asthma. The key advantages of inhalation therapy arise from the 
direct targeting of the drug to the site of action. This results in more rapid onset of therapeutic effect, fewer systemic 
side effects and lower doses, giving an improved safety profile in comparison with for example, oral therapy [1, 2]. 
PMDIs are the most popular aerosol devices used for inhalation therapy. However, one of the most significant 
drawbacks of pMDI systems is that drug deposition commonly appears on the hardware of the device, from 
suspension-based formulations [2, 4]. Such drug deposition (caking), may result in ineffective drug therapy due to 
low or inconsistent dosing [5, 6]. There are several published studies on drug deposition phenomena in pMDI 
devices, most of which focus on stabilisation of the formulation by the use of either excipients, surfactants or particle 
engineering techniques [7, 8]. Further studies focus on the effect of both moisture and temperature storage 
conditions to the drug caking appearing on the device [9, 10]. Other investigations explore the effect of hardware 
design to the performance of pMDIs [11, 12]. However, there are limited studies concerning surface treatments 
applied to the hardware of the inhaler i.e. cleaning methods and coating procedures [13, 14]. The aim of this study 
was to explore drug deposition behaviour on pMDI canisters employing a range of surface treatments and to relate 
this to surface topography and surface chemistry. 
Experimental 
Section 1 Physicochemical characterisation of the aluminium canisters,  
In order to observe the effect of different surface treatments on surface morphology, surface elemental composition 
and total surface energy of the samples, three different techniques were applied to the samples: Scanning Electron 
Microscopy (SEM), X-Ray Photoelectron Spectroscopy (XPS), and Contact Angle (CA) analysis. The results 
obtained are presented below.  
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Scanning Electron Microscopy (SEM)  
The SEM technique was used to acquire high resolution information on sample surface topography. The results are 
presented in Fig 1.  
  
 
 
  
 
 
Figure 1: Surface topography of aluminium canisters after various surface treatments were applied 
In Figure 1, it is seen that the anodisation treatment produced a significantly smoother surface topography 
(Figure1b) compared to the original surface (Figure 1a). In contrast the Parylene coating treatment masked only 
the fine topography of the sample (Figure 1c). Finally, complete masking of the aluminium surface irregularities was 
observed with the FEP coating treatment (Figure 1d).  
X-Ray photoelectron Spectroscopy Analysis  
The aim of the XPS analysis was to determine the surface chemical composition of the aluminium canisters before 
and after coating application. The results are shown in Table 1. 
 
 
Sample Al C Cl F Mg O S Si N Ni 
Novec 72DE cleaned can 26.46 26.80 0.00 0.00 5.30 41.40 0.00 0.00 0.00 0.00 
FEP coated can 0.00 35.30 0.00 64.7 0.00 0.00 0.00 0.00 0.00 0.00 
Parylene coated can 0.00 83.80 12.68 0.31 0.00 2.28 0.00 0.92 0.00 0.00 
Anodised can 22.57 33.00 0.00 0.00 0.00 38.50 3.10 0.00 0.86 2.00 
Anodised + 3M fluorosilane 
can 
13.71 31.73 0.00 26.89 0.00 22.87 1.83 0.00 0.67 2.30 
3M flurosilane can 6.55 29.22 0.00 48.62 0.00 15.61 0.00 0.00 0.00 0.00 
Figure 1a: Surface of the Aluminium 
Can after solvent cleaning process 
x1000 Magnification 
Figure 1b: Surface of the Aluminium Can 
after Anodisation Surface treatment 
x1000 Magnification 
Figure 1c: Surface of the Aluminium 
Can after Parylene coating Surface 
treatment x1000 Magnification 
Figure 1d: Surface of the Aluminium 
Can after FEP coating Surface 
treatment x1000 Magnification 
Table 1: Surface chemical composition atomic%, excluding H and He, of the aluminium canisters after various 
coating treatments applied 
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In Table 1 the surface elemental composition of the cans, after the application of various treatments is shown. 
These data indicate that the coatings have created specific surface chemistry.  The absence of detectable 
aluminium at the surface for both the FEP and the Parylene coatings suggests that both coating types completely 
mask the surface. The high percentages of fluorine for both the FEP coating and for the 3M fluorosilane coating 
applied directly onto the aluminium canister suggest that effective non-stick performance might be expected for 
these systems.  The high percentages of both carbon and chlorine are both characteristic of the Parylene coating 
and the high percentages of aluminium along with oxygen were seen with the anodised canister surface.  
Contact angle analysis 
The aim of the Contact Angle technique was to quantify the surface hydrophobicity and the total surface energy of 
the samples. The results are shown n Table 2. 
 
Sample 
CA 
Water(°) 
CA DIM (°) 
Total 
Surface 
Energy 
(mN/m) 
Dispersive 
component 
(mN/m) 
Polar 
component 
(mN/m) 
Novec 72DE cleaned alum can  87.90 56.80 30.05 27.46 2.59 
FEP coated alum can  101.70 77.40 18.59 17.27 1.32 
Parylene coated alum can  84.10 39.70 39.17 37.48 1.69 
Anodised alum can 80.60 41.30 38.44 35.36 3.08 
Anodised+3M fluorosilane alum can 106.50 86.00 15.87 14.53 1.34 
3M fluorosilane coated alum can 112.60 84.20 15.73 15.41 0.32 
 
The sessile drop technique was used for the acquisition of the contact angle data. The Surface Energy calculation 
employed was that of Owens-Wendt and Kaelble (OWK). A two-liquid method was employed using Deionised Water 
(a polar liquid) and Diiodomethane (DIM) (a non-polar liquid). This method allows the surface energy to be 
expressed in terms of polar and dispersion components. The DIM is used in order to detect surface energy due to 
dispersive interactions and water is used to detect surface energy due to polar interactions [15, 16]. The results 
indicated a range of values of the total surface energy and of the polar and dispersive elements of the surface 
energy across the samples. The lowest total surface energy was seen with the use of the 3M fluorosilane final 
treatment, while the highest total surface energy was observed with the Parylene coated sample. Notable is the 
significant decrease of the total surface energy observed with the anodised can, following application of the 3M 
fluorosilane as a final treatment. 
Section 2 Application of drug deposition testing to the treated aluminium canisters.  
The canisters were subjected to a previously published rapid screening deposition test based on the controlled 
deposition of micronised salbutamol sulphate particles on the internal surface of canisters, followed by rinsing steps, 
followed by the assay of residual surface salbutamol sulphate deposition [14]. The results are shown in Figure 2. 
 
Figure 2 Deposition performance of aluminium canisters with different surface treatments 
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Table 2 Contact Angle and total Surface Energy of the aluminium canisters after surface treatment application 
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In Figure 2, the deposition performance of the aluminium canisters, after different surface treatments, is shown. 
Two to three replicates were used in each case. The canisters labelled “Calibration” provide a test reference point 
defining 100% deposition, as the salbutamol sulphate suspension has been applied to these canisters but without 
subsequent rinsing. The salbutamol sulphate suspension was applied to the remaining test canisters with the 
addition of two separate fluid rinses, employing decafluoropentane (5ml) with five 180 degree inversion shakes of 
1 second cycle duration for each rinse. From the results obtained it is observed that the highest drug deposition 
occurred with the Parylene coated sample, while the lowest drug deposition occurred with the 3M fluorosilane 
coated sample. Notable is the decrease in drug deposition for the solvent-washed and the anodised sample, when 
followed by the 3M fluorosilane as a final treatment. 
Discussion 
Viewing all experimental data as a whole, it can be seen that, in general terms, FEP and fluorosilane coatings give 
rise to high measured surface fluorine levels, which in turn correlate to low deposition performance. Although FEP 
provides the smoothest coating, the key driver for deposition appears to be surface energy, since the fluorosilane 
coatings do not significantly alter the topography of the can surface, yet perform slightly better than the FEP coating 
in terms of measured deposition. The Parylene coated canister shows both higher surface energy and higher 
deposition than the uncoated canister yet is topographically smoother then the uncoated canister, which further 
supports the argument that surface energy is the key driver to reducing deposition.   
Conclusions 
Drug deposition on pMDI canisters was shown to vary considerably across a range of samples with different 
coatings applied. Deposition was found to correlate very strongly with total surface energy rather than surface 
topography. Hence coatings depositing high surface fluorine and providing low surface energy, irrespective of 
topography, gave the best performance. Further work will focus on developing a deeper understanding of the 
variables in coating application, deposition test methodology and fluorosilane chemistry on measured deposition 
performance.    
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